Evidence map›Paper›PMID 28723580›Full record

ArticleJournal of biomedical informatics2017

Quality assurance of chemical ingredient classification for the National Drug File - Reference Terminology.

Ling Zheng, Hasan Yumak, Ling Chen, Christopher Ochs, James Geller, Joan Kapusnik-Uner, Yehoshua Perl

Abstract read
In one paragraph

Article in Journal of biomedical informatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Missing lateral relationships in top-level concepts of an ontology.BMC medical informatics and decision making · 2020
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ling ZhengDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ 07102, United States. Electronic address: lz265@njit.edu.
Hasan YumakBMCC, CUNY, New York, NY 10007, United States. Electronic address: hyumak@bmcc.cuny.edu.
Ling ChenBMCC, CUNY, New York, NY 10007, United States. Electronic address: lchen@bmcc.cuny.edu.
Christopher OchsDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ 07102, United States. Electronic address: cro3@njit.edu.
James GellerDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ 07102, United States. Electronic address: james.geller@njit.edu.
Joan Kapusnik-UnerFirst Databank Inc., San Francisco, CA 94080, United States. Electronic address: jkapusnik-uner@fdbhealth.com.
Yehoshua PerlDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ 07102, United States. Electronic address: perl@njit.edu.

Funding

A family-based framework of quality assurance for biomedical ontologiesR01CA190779 · NCI · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI PERL, YEHOSHUA · 2015 to 2017
$1.8M
NCI NIH HHS R01 CA190779
6 · The paper itself

Abstract

The National Drug File - Reference Terminology (NDF-RT) is a large and complex drug terminology consisting of several classification hierarchies on top of an extensive collection of drug concepts. These hierarchies provide important information about clinical drugs, e.g., their chemical ingredients, mechanisms of action, dosage form and physiological effects. Within NDF-RT such information is represented using tens of thousands of roles connecting drugs to classifications. In previous studies, we have introduced various kinds of Abstraction Networks to summarize the content and structure of terminologies in order to facilitate their visual comprehension, and support quality assurance of terminologies. However, these previous kinds of Abstraction Networks are not appropriate for summarizing the NDF-RT classification hierarchies, due to its unique structure. In this paper, we present the novel Ingredient Abstraction Network (IAbN) to summarize, visualize and support the audit of NDF-RT's Chemical Ingredients hierarchy and its associated drugs. A common theme in our quality assurance framework is to use characterizations of sets of concepts, revealed by the Abstraction Network structure, to capture concepts, the modeling of which is more complex than for other concepts. For the IAbN, we characterize drug ingredient concepts as more complex if they belong to IAbN groups with multiple parent groups. We show that such concepts have a statistically significantly higher rate of errors than a control sample and identify two especially common patterns of errors.

Indexed as

Pharmaceutical PreparationsTerminology as TopicVocabulary, ControlledHumansQuality ControlPharmaceutical PreparationsAuditing chemical ingredientsAuditing NDF-RTChemical Ingredients hierarchyDrug terminologyNational Drug File – Reference TerminologyNDF-RT quality assurance

Identifiers

PMID28723580
PMCPMC5652327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.